Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Usha G Mallya"'
Autor:
April W Armstrong, Ahong Huang, Li Wang, Raymond Miao, Miraj Y Patel, Abhijit Gadkari, Usha G Mallya, Jingdong Chao
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210517 (2019)
At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis included off-label immunosuppressants and corticosteroids. Immunosuppressant therapy is ass
Externí odkaz:
https://doaj.org/article/60530dbd20c94b2797e1c2c246099422
Autor:
Peter Kühnen, Martin Wabitsch, Julia von Schnurbein, Costel Chirila, Usha G. Mallya, Patrick Callahan, Ari Gnanasakthy, Christine Poitou, Philipp M. Krabusch, Murray Stewart, Karine Clément
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Introduction Individuals with proopiomelanocortin (POMC) or leptin receptor (LEPR) deficiency are young and experience severe obesity, hyperphagia, and comorbidities, which can impair quality of life (QOL). Methods Two pivotal Phase 3 trials
Externí odkaz:
https://doaj.org/article/4c5949b639f04cd3b88c6a643bb6e70e
Autor:
Claire Ervin, Lindsey Norcross, Usha G. Mallya, Sheri Fehnel, Robert S. Mittleman, Matthew Webster, Andrea M. Haqq, Robert M. Haws
Publikováno v:
Advances in Therapy. 40:2394-2411
Publikováno v:
Endocrine Abstracts.
Autor:
Timothy A. Howell, Louis S. Matza, Usha G. Mallya, Anthony P. Goldstone, W. Scott Butsch, Ethan Lazarus
Publikováno v:
Obesity Science & Practice.
Objective Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperph
Autor:
Elizabeth Forsythe, Robert M. Haws, Jesús Argente, Philip Beales, Gabriel Á. Martos-Moreno, Hélène Dollfus, Costel Chirila, Ari Gnanasakthy, Brieana C. Buckley, Usha G. Mallya, Karine Clément, Andrea M. Haqq
Publikováno v:
Orphanet Journal of Rare Diseases. 18
Background Bardet–Biedl syndrome is a rare genetic disease associated with hyperphagia and early-onset, severe obesity. There is limited evidence on how hyperphagia and obesity affect health-related quality of life in patients with Bardet–Biedl s
Autor:
Debra Sierka, Jessica J. Jalbert, Cheng Chen, Haixin Zhang, Andrew Korotzer, Vera Mastey, Mandeep Kaur, Zhen Chen, Usha G. Mallya, Miriam C. Fenton, Abhijit Gadkari, Emma Guttman-Yassky, Jonathan I. Silverberg, Andreas Kuznik
Publikováno v:
Annals of Allergy, Asthma & Immunology. 126:40-45
Background The real-world persistence with dupilumab therapy for atopic dermatitis (AD) is unknown. Objective To characterize adults with AD who initiated dupilumab and evaluate persistence with dupilumab therapy. Methods This retrospective cohort st
Autor:
Usha G. Mallya, Julie Héroux, Amy S. Paller, Abhijit Gadkari, Francis Vekeman, Mandeep Kaur, Elaine C. Siegfried, Raymond Miao, Paola Mina-Osorio
Publikováno v:
BMC Dermatology, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Dermatology
BMC Dermatology
Background An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty care. These factors affect treatment utilization for pediatric patients with atop
Autor:
Min Yang, Jingdong Chao, Mirko Fillbrunn, Usha G Mallya, Min-Jung Wang, Leigh Franke, Lauren Cohn, Siddhesh Kamat
Publikováno v:
Patient preference and adherence. 16
Min Yang,1 Jingdong Chao,2 Mirko Fillbrunn,1 Usha G Mallya,3 Min-Jung Wang,1 Leigh Franke,1 Lauren Cohn,4,5 Siddhesh Kamat2 1Analysis Group, Inc, Boston, MA, USA; 2Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA; 3Sanofi, Boston, MA, USA; 4Section
Autor:
Martin Wabitsch, Sheri Fehnel, Usha G. Mallya, Martina Sluga-O’Callaghan, David Richardson, Mark Price, Peter Kühnen
Publikováno v:
Advances in therapy. 39(4)
In patients with pro-opiomelanocortin (POMC) or leptin receptor (LEPR) deficiency, managing obesity and hyperphagia can be burdensome for patients and caretakers. The impacts on health-related quality of life are under-recognized and are not well cha